Received: May 03, 2021; Accepted: May 17, 2021; Published: May 24, 2021 Uncontrolled and abnormal cell growth in the brain is called a brain tumour. The space in our skull is restricted. Therefore, this extra growth inside our brain causes more pressure inside the skull, causing life...
Glioblastoma, the deadly brain cancer that impacts about 12,000 people in the U.S. each year, remains one of the most significant unmet medical needs facing the healthcare industry. The five-year survival rate is under 10% and patients survive an average of 15 to 18 months after diagnosis...
Researchers at the University of Nottingham have discovered that repurposing a heart drug could significantly increase the survival rate for children with ependymoma—a type of brain tumor. The findings, published inScientific Reportsand led by experts in the University's Schools of Medicine and Life ...
For all tumor types (740 patients), the actuarial survival rate was 8.1% at 2 y, 4.8% at 3 y, and 2.4% at 5 y. At 2 y, patients with ovarian carcinoma had the highest survival rate (23.9%) and patients with small cell lung cancer (SCLC) had the lowest survival rate (1.7%). ...
With the maximum of 30 years of follow-up, secondary tumors developed in 31 patients, for an actuarial rate of 13% at 20 years. This appears to be quite high, but it is important to note that of the 546 deaths in the study population, 514 were caused by "disease", as opposed to ...
Thus I3C exhibits anticancer activities by suppressing breast tumor cell growth and metastatic spread. A gas chromatography-mass spectrometry method for the quantitation of diindolylmethane, the principal acid condensation product of I3C, has ... DW Sepkovic,HL Bradlow,M Bell - 《Nutrition & Cancer...
Article Open access 18 March 2020 Survival impact of the time gap between surgery and chemo-radiotherapy in Glioblastoma patients Article Open access 12 June 2020 Introduction Glioblastoma multiforme is the most common primary malignant brain tumour in adults with an incidence rate of 3.7 per 100...
Compared to RT therapy alone, the combination of RT and TMZ significantly increased the median overall survival for GBM patients by 2.5 months (median overall survival 12.1 months and 14.6 months, respectively) and the two-year survival rate was 10.4% for RT alone compared to 26.5% for GBM ...
Moreover, there was no difference in the rate of adverse events between the two groups, except for mild to moderate skin irritation on the scalp, which was experienced by slightly more than half of patients receiving the TTFields therapy. ...
Despite the substantial rate of neck conversion reported among patients with early oral cancer, a policy of routine elective neck dissection has been criticized on the grounds that it confers little survival advantage while subjecting many to potentially avoidable morbidity. However, the identification ...